Bisphosphonate osteochemonecrosis (bis-phossy jaw): Is this phossy jaw of the 21st century?

Journal of Oral and Maxillofacial Surgery

Volumn 63, Issue 5, 2005, Pages 682-689

  Hellstein, John W ^a   Marek, Cindy L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; COPPER SULFATE;

ALBERS SCHOENBERG DISEASE; BACTERIAL OVERGROWTH; BISPHOSPHONATE OSTEOCHEMONECROSIS; BONE DENSITY; BONE NECROSIS; CANCER CHEMOTHERAPY; DEBRIDEMENT; HISTOPATHOLOGY; HUMAN; HYPERBARIC OXYGEN; INFLAMMATORY INFILTRATE; JAW DISEASE; MANDIBLE RESECTION; MAXILLA RESECTION; MOUTH HYGIENE; OSTEOCLAST; PHOSSY JAW; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE;

EID: 18044392927     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2005.01.010     Document Type: Article

References (59)

1. B. Kessel Hip fracture prevention in postmenopausal women Obstet Gynecol Surv 59 2004 446
2. S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg Osteonecrosis of the jaws associated with the use of bisphosphonates A review of 63 cases J Oral Maxillofac Surg 62 2004 527
3. M. Marketos The top 200 brand drugs in 2003 (by units) Drug Topics 148 2004 76
4. J. Berenson, R. Hirschberg Safety and convenience of a 15-minute infusion of zoledronic acid Oncologist 9 2004 319
5. P. Conte, V. Guarneri Safety of intravenous and oral bisphosphonates and compliance with dosing regimens Oncologist 9 suppl 4 2004 28
6. M.B. O'Connell, M.E. Elliot Osteoporosis and osteomalacia T. DiPiro Pharmacotherapy A Pathophysiologic Approach 5th ed 2002 McGraw-Hill New York, NY 1690
7. J.E. Dunford, K. Thompson, F.P. Coxon Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates J Pharmacol Exp Ther 296 2001 235
8. C. Vitte, H. Fleisch, H.L. Guenther Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption Endocrinology 137 1996 2324
9. P. Fournier, S. Boissier, S. Filleur Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats Cancer Res 62 2002 6538
10. J. Wood, K. Bonjean, S. Ruetz Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid J Pharmacol Exp Ther 302 2002 1055
11. D.P. Pioletti, L.R. Rakotomanana Can the increase of bone mineral density following bisphosphonates treatments be explained by biomechanical considerations? Clin Biomech 19 2004 170
12. J.A. Smith Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer The effect of bisphosphonate therapy on bone scintigraphy results Urol Oncol 21 2003 483
13. H.K. Oh, M.S. Chambers, A.S. Garden Risk of osteoradionecrosis after extraction of impacted third molars in irradiated head and neck cancer patients J Oral Maxillofac Surg 62 2004 139
14. L.A. Assael New foundations in understanding osteonecrosis of the jaws J Oral Maxillofac Surg 62 2004 125
15. G.D. Carter, A.N. Goss Bisphosphonates and avascular necrosis of the jaws Aust Dent J 48 2003 268
16. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws A growing epidemic J Oral Maxillofac Surg 61 2003 1115
17. C.A. Migliorati Bisphosphonates and oral cavity avascular bone necrosis J Clin Oncol 21 2003 4253
18. P. Tarassoff, K. Csermak Avascular necrosis of the jaws Risk factors in metastatic cancer patients J Oral Maxillofac Surg 61 2003 1238
19. G.G. Reinholz, B. Getz, E.S. Sanders Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells Identity of a potent new bisphosphonate analogue Breast Cancer Res Treat 71 2002 257
20. G.G. Reinholz, B. Getz, L. Pederson Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts Cancer Res 60 2000 6001
21. G.I. Im, S.A. Qureshi, J. Kenney Osteoblast proliferation and maturation by bisphosphonates Biomaterials 25 2004 4105
22. W.F. Dearden The causation of phosphorus necrosis BMJ 2 1901 408
23. W.F. Dearden Fragilitas ossium amongst workers in Lucifer match factories BMJ 2 1899 270
24. Editor's Note Phosphorus necrosis under control B Dent J 76 1944 343
25. A.E. Miles Phosphorus necrosis of the jaw 'Phossy jaw' Br Dent J 133 1972 203
26. S.M. Aronson The Salvation Army and phossy jaw Med Health R I 80 1997 315
27. A. Hamilton, H.L. Hardy Industrial Toxicology 2nd ed 1949 Paul B. Hoeber, Inc New York, NY 138 144
28. A. Hamilton, H.L. Hardy, A.J. Finkel Hamilton and Hardy's Industrial Toxicology 4th ed 1983 John Wright, PSG Inc Boston, MA 116 120
29. J.P. Hughes, R. Baron, D.H. Buckland Phosphorus necrosis of the jaw A present-day study Br J Ind Med 19 1962 83
30. B.G. Wakefield Phosphorus necrosis of the mandible J Oral Surg 6 1948 264
31. C.O. Adams, B.G. Sarnat Effects of yellow phosphorus and arsenic trioxide on growing bones and growing teeth Arch Pathol 30 1940 1192
32. R. Kennon, J.W. Hallam Modern phosphorus caries and necrosis Br Dent J 76 1944 321
33. H. Heiman Chronic phosphorus poisoning J Indust Hyg 28 1946 142
34. K.H. Thoma, H.M. Goldman Oral Pathology 5th ed 1960 Mosby St Louis, MO 709
35. K.H. Thoma Oral Pathology 1941 Mosby St Louis, MO 815 836
36. NationMaster.com: Phosphorus. www.nationmaster.com/encyclopedia/ Phosphorus. Accessed March 8, 2005
37. US Department of Health and Human Services: Toxicological profile for white phosphorus. http://www.atsdr.cdc.gov/toxprofiles/tp103.pdf. Agency for toxic substances and disease registry. Accessed March 31, 2005
38. M.L. Myers, J.D. McGlothlin Matchmakers' "phossy jaw" eradicated Am Ind Hyg Assoc J 57 1996 330
39. E.F. Ward Phosphorus necrosis in the manufacture of fireworks J Indust Hyg 10 1928 314
40. T. Blum Osteomyelitis of the mandible and maxilla J Am Dent Assoc 11 1924 802
41. J.L. Bernier, H.M. Goldman Atlas of Dental and Oral Pathology (3rd ed) 1944 Armed Forces Institute of Pathology Washington, DC 156 157
42. C. Clark Radium Girls 1997 The University of North Carolina Press Chapel Hill, NC 65 86
43. K.H. Thoma Oral Pathology 4th ed 1954 Mosby St Louis, MO 760 767
44. R.W. Tiecke Oral Pathology 1965 McGraw-Hill New York, NY 545-545
45. H.H. Sherk, S. Harrison, M.D. Martland The radium watch-dial workers and the evolution of industrial medicine N J Med 98 2001 49
46. W.L. Watson, J.E. Scarborough Osteoradionecrosis in intraoral cancer Am J Roentgenol Rad Therapy 40 1938 524
47. S.A. Jakhi, B.K. Parekh, S. Gupta Phosphorus necrosis of the maxilla J Oral Med 38 1983 174
48. R.E. Marx Osteoradionecrosis A new concept of its pathophysiology J Oral Maxillofac Surg 41 1983 283
49. I. Sunshine Dr Alexander O. Gettler's documentation of a radiation hazard Am J Forensic Med Pathol 4 1983 307
50. F.J. Cronje A review of the Marx protocols Prevention and management of osteoradionecrosis by combining surgery and hyperbaric oxygen therapy S A Dent J 53 1998 469
51. R.A. Myers, R.E. Marx Use of hyperbaric oxygen in postradiation head and neck surgery NCI Monogr 9 1990 151
52. S. Vudiniabola, C. Pirone, J. Williamson Hyperbaric oxygen in the therapeutic management of osteoradionecrosis of the facial bones Int J Oral Maxillofac Surg 29 2000 435
53. M.P. Whyte, D. Wenkert, K.L. Clements Bisphosphonate-induced osteopetrosis N Engl J Med 349 2003 457
54. J.E. Bouquot, R.E. McMahon Charlatans in dentistry Ethics of the NICO wars J Am Coll Dent 70 2003 38
55. J.R. Zuniga Challenging the neuralgia-inducing cavitational osteonecrosis concept J Oral Maxillofac Surg 58 2000 1021
56. E.C. Li, L.E. Davis Zoledronic acid A new parenteral bisphosphonate Clin Ther 25 2003 2669
57. B. Chern, D. Joseph, D. Joshua Bisphosphonate infusions Patient preference, safety and clinic use Support Care Cancer 12 2004 463
58. A.G. Novartis Zometa (zoledronic acid) injection Product Information Sheet, Novartis AG 2004 1
59. A.G. Novartis Aredia pamidronate disodium for injection, For intravenous infusion Product Information Sheet, Novartis AG 2004 1